Clinical Trials Directory

Trials / Completed

CompletedNCT02239484

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

An Open-label, Randomized, Multiple-dose Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Hanmi Pharmaceutical Company Limited · Industry
Sex
Male
Age
19 Years – 55 Years
Healthy volunteers
Accepted

Summary

We investigate the potential pharmacokinetic drug-drug interaction between Tadalafil and Tamsulosin in healthy male volunteers who receive Tadalafil alone, Tamsulosin alone, and both together in a 3 period repeatedly.

Conditions

Interventions

TypeNameDescription
DRUGTadalafil
DRUGTamsulosin
DRUGTadalafil + Tamsulosin

Timeline

Start date
2014-03-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2014-09-12
Last updated
2014-09-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02239484. Inclusion in this directory is not an endorsement.

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin (NCT02239484) · Clinical Trials Directory